THE ROLE OF BUSULFAN CYCLOPHOSPHAMIDE REGIMENS IN ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION

被引:11
作者
BRODSKY, I
BULOVA, S
CRILLEY, P
机构
关键词
D O I
10.3109/07357908909041380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:509 / 513
页数:5
相关论文
共 23 条
[1]   THE BIOLOGICAL SIGNIFICANCE OF THE CHANGES PRODUCED IN THE DEOXYRIBONUCLEIC ACID OF CELLS TREATED WITH RADIOMIMETIC ALKYLATING AGENTS [J].
ALEXANDER, P ;
LETT, JT .
BIOCHEMICAL PHARMACOLOGY, 1960, 4 (1-4) :34-46
[2]   CHEMOTHERAPY OF PLASMA-CELL MYELOMA AND THE INCIDENCE OF ACUTE-LEUKEMIA [J].
BERGSAGEL, DE ;
BAILEY, AJ ;
LANGLEY, GR ;
MACDONALD, RN ;
WHITE, DF ;
MILLER, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (14) :743-748
[3]   INCREASED INCIDENCE OF ACUTE-LEUKEMIA IN POLYCYTHEMIA-VERA ASSOCIATED WITH CHLORAMBUCIL THERAPY [J].
BERK, PD ;
GOLDBERG, JD ;
SILVERSTEIN, MN ;
WEINFELD, A ;
DONOVAN, PB ;
ELLIS, JT ;
LANDAW, SA ;
LASZLO, J ;
NAJEAN, Y ;
PISCIOTTA, AV ;
WASSERMAN, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (08) :441-447
[4]   PLATELET DNA-POLYMERASE LEVELS IN CML - IMPLICATIONS FOR ONCOGENESIS [J].
BRODSKY, I ;
STRAYER, DR ;
GILLESPIE, DH .
LEUKEMIA RESEARCH, 1984, 8 (05) :761-&
[6]  
BRODSKY I, 1982, BIOMED PHARMACOTHER, V36, P125
[7]   ANALYSIS OF PLATELETS FROM PATIENTS WITH THROMBOCYTHEMIA FOR REVERSE-TRANSCRIPTASE AND VIRUS-LIKE PARTICLES [J].
BRODSKY, I ;
FUSCALDO, AA ;
ERLICK, BJ ;
KINGSBURY, EW ;
SCHULTZ, GM ;
FUSCALDO, KE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (05) :1069-1074
[8]   EFFECT OF BUSULFAN ON ONCORNAVIRUS-LIKE ACTIVITY IN PLATELETS AND CHROMOSOMES IN POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA [J].
BRODSKY, I ;
FUSCALDO, AA ;
ERLICK, BJ ;
FUSCALDO, KE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (01) :61-67
[9]   REACTION OF MONO- AND DI-FUNCTIONAL ALKYLATING AGENTS WITH NUCLEIC ACIDS [J].
BROOKES, P ;
LAWLEY, PD .
BIOCHEMICAL JOURNAL, 1961, 80 (03) :496-&
[10]  
DUNN CDR, 1974, EXP HEMATOL, V2, P101